Rimidi News & Insights

See what's new at Rimidi

Read our blog posts below.

Diabetes and Heart Disease

Most people with diabetes do not realize that heart disease is one of the more serious and common complications of having diabetes. The classic microvascular complications of the eye, kidney, and nerves are commonly discussed and more often stressed in the diabetes literature, even though they occur much less frequently than cardiovascular disease. Heart attacks, […]

The Kinetix Group Partners with Rimidi to Launch a Clinical Care Partnership for the Management of Nonalcoholic Steatohepatitis (NASH)

NEW YORK, Aug. 30, 2018 /PRNewswire/ — The Kinetix Group in partnership with Rimidi, an Atlanta-based health care technology firm, announced a partnership focused on improving Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) care delivery leveraging NASHNET, a global centers of excellence network. The Kinetix Group (PRNewsFoto/The Kinetix Group) (PRNewsfoto/The Kinetix Group) The global NASH market is […]

Rimidi Announces Addition of Jim Clifford as Vice President of Strategic Sales

ATLANTA, Aug. 27, 2018 /PRNewswire/ — Rimidi, a digital health company that provides software and clinical analytics for chronic disease management, today announced that Jim Clifford has joined the company as Vice President of Strategic Sales. “Jim’s joining Rimidi is a great win for the company and for our clients. Jim’s depth of experience and knowledge of HIT will bring enormous […]

Diabetes Education: We Can Do Better

Lifestyle management has been the cornerstone of diabetes treatment since the disease was first identified.  Insulin and medications are actually relative newcomers to the options available for treatment. Every major diabetes organization recommends diabetes self-management education and support (DSMES) is part of standard care for all individuals with diabetes. The benefits of DSMES are many […]

Its more than Diabetes!

Cardio-Metabolic chronic diseases are plaguing the US population and are creating an untenable level of cost to the US healthcare system. Although there is a growing public awareness of the pervasiveness and impact of Diabetes, there is less concerning the chronic disease states that co-exist with Diabetes. The infographic demonstrates the need for a strong […]

Diabetes – hasn’t that been solved?

No. The ‘diabetes problem’ has not been solved. In fact, despite the advances in blood glucose monitoring technologies, the proliferation of self-management apps, and near universal awareness of the impact of poorly-controlled diabetes, we haven’t significantly changed the trends on prevalence, outcomes or cost. Yet. Here’s an example of hemoglobin A1c control at a very […]

Twisted Healthcare Economics

Despite the high cost of healthcare in the US, numerous forces are converging to put pressure on hospital margins; 30% of hospitals are losing money. Some forces like policy, payer mix and workforce changes, are out of the control of the hospital, but others can be addressed. In particular, revenue cycle management innovations can be implemented […]

New MIPS Improvement Activity Supports RPM

This article is featured on AJMC and was co-written by Caroline Meade, MPH candidate. Telehealth is a growing market with a compound annual growth rate of 39.9%, more than double that of health information technology. Despite growth in the market, CMS has been slow to recognize the value that telehealth can bring to clinical encounters by […]

Rimidi appoints Josh Claman as CEO

ATLANTA and AUSTIN, Texas, Jan. 9, 2018 /PRNewswire/ — Rimidi, a digital health company that provides software and clinical analytic s for chronic disease management, today announced that it has appointed Austin-based Josh Claman as president and chief executive officer effective January 8, 2018.  Dr. Lucienne M. Ide, Rimidi’s co-founder and current CEO, will continue to serve as chairman of Rimidi’s board of directors. “Josh […]

Rimidi and Lilly Collaborate to Personalize Solutions for People Using Insulin

Companies will strive to make diabetes management easier through effective use of connected devices and a diabetes management software platform INDIANAPOLIS and ATLANTA, Dec. 14, 2017 /PRNewswire/ — Rimidi, a digital health company that provides software and clinical analytics for chronic disease management, and Eli Lilly and Company (NYSE: LLY), a leader in diabetes care for more than 90 years, are coming […]

SMART on FHIR is changing healthcare – Rimidi joins Cerner Marketplace

Rimidi is on fire because of FHIR. We just launched our Diabetes+Me application in Cerner’s app marketplace, an improtant milestone in interoperability for us as a company. Rimidi is a digital health company providing software and clinical analytics for chronic disease management. Our goal is to make it easier for people with diabetes and their healthcare providers to manage […]

Rimidi Partners with Dexcom for the Launch of Their Data Platform

Rimidi, a provider of digital health solutions to improve the management of chronic diseases, is an inaugural data partner in Dexcom’s newly launched open data platform. Dexcom is a leading continuous glucose monitoring (GCM) company, and its public API enables  third-party developers to connect patient-authorized CGM data into a broad range of software applications. This pioneering approach […]